Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05916378
Collaborator
The Latino Cancer Institute (Other)
150
1
12
12.5

Study Details

Study Description

Brief Summary

The purpose of this study is to identify the barriers, and the extent of said barriers, to genomic testing for breast cancer patients among low-income and minority populations, particularly throughout Northern California. We have created a survey that is available online for any patient with cancer to fill out voluntarily regarding their experiences to date. The survey is available at: https://stanforduniversity.qualtrics.com/jfe/form/SV_7VElf8oesWcB3bE

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The study has two main data-collecting phases. In phase 1, we will engage multilevel stakeholders to respond to a survey assessing experience with and perceptions of genomic testing and its accessibility for patients with breast cancer in California. In phase 2, selected and interested survey participants who voluntarily provide their contact information on the survey will be asked to participate in an in-depth 1:1 semi-structured interview to explore disparities in genomic testing for breast cancer more closely. We will then utilize our findings from both phases to present aggregate findings to an Expert Panel and Community Advisory Board and work together to develop policy recommendations. The policy recommendations will then be presented to policy makers, with the aim of identifying sustainable solutions that address breast cancer treatment and outcome disparities throughout Northern California.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies
    Actual Study Start Date :
    May 22, 2023
    Anticipated Primary Completion Date :
    Oct 31, 2023
    Anticipated Study Completion Date :
    May 22, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Patients and Caregivers

    We will survey 100 patients and 50 caregivers.

    Outcome Measures

    Primary Outcome Measures

    1. Number of participants who fill out the survey and participate in the semi-structured interviews. [ Time Frame: 12 Months ] [12 Months]

      We will track the number of participants who fill out the survey for the 12 month duration of the study and the number of participants who participate in the semi-structured telephone interviews.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 99 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • The patients must be 18 years or older.

    • Patients who opt in to complete the survey.

    • Patients must have the capacity to verbally consent for the interview.

    Exclusion Criteria:
    • Patients who under the age of 18 years old.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University School of Medicine Stanford California United States 94305

    Sponsors and Collaborators

    • Stanford University
    • The Latino Cancer Institute

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Manali Indravadan Patel, Principal Investigator, Stanford University
    ClinicalTrials.gov Identifier:
    NCT05916378
    Other Study ID Numbers:
    • 68742
    First Posted:
    Jun 23, 2023
    Last Update Posted:
    Jun 23, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Manali Indravadan Patel, Principal Investigator, Stanford University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 23, 2023